Metabolic Health as an Essential Consideration When Using Antipsychotic Medications
An on-demand article for healthcare professionals seeking to support the metabolic health of patients prescribed antipsychotic medications.
- Contact hours: 1.0 (0.10 CEU)
- Registration is free of charge
Activity Description
Antipsychotic medications may induce or worsen metabolic abnormalities such as weight gain, glucose dysregulation, and hyperlipidemia. Action should be taken to minimize metabolic-related risks of antipsychotic medications whenever possible. Such actions may include choosing agents with a lower propensity to impact metabolic parameters and routinely monitoring for metabolic disturbances. Although the rationale for metabolic monitoring remains clear and consistent, monitoring rates have been shown to be less than optimal, regardless of antipsychotic formulation. This written continuing education activity summarizes evidence-based strategies for the prevention and management of metabolic side effects of antipsychotic medications.
- Discuss the metabolic side effects associated with use of antipsychotic medications.
- Identify appropriate monitoring parameters and schedules for metabolic side effects in patients treated with antipsychotic medications.
- Describe strategies for the management of metabolic side effects of antipsychotic medications.
Activity Contributors
Intended Audience
Physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare providers.
Cost and Registration
There is no fee for this activity. The program is supported by the New York State Department of Health Medicaid Prescriber Education Program (MPEP).
Accreditation and Certification Information
For physicians/providers:
Accreditation: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
Certification: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this internet enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For pharmacists:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE # 0044-9999-24-018-H01-P and will award 1.0 contact hours (0.10 CEU) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor for those who complete all components of this activity.
